Teladoc soars 26% as revenue and profit beat estimates; Hims & Hers Health and American Well tick up. Teladoc posted falling revenue yet still managed to beat Wall Street on both sales and profit, sending shares surging. The real question is whether a surprising shift inside its BetterHelp unit can turn a struggling business into a growth story. Shrinking revenue hasn't kept Teladoc Health (NYSE:TDOC) from beating estimates on both sales and earnings. Early signs that its BetterHelp mental health business can shift toward insurance-covered care are giving investors a reason to bid the stock up significantly. Teladoc stock is at $8.76, up 26% around midday. Taking a look at Teladoc Health's peers, Hims & Hers Health (NYSE:HIMS) stock is at $29.89, up 2%. American Well (NYSE:AMWL) stock is at $14.21, up 0.64%. Teladoc beats on revenue and profit as BetterHelp shifts to insurance. Key data−. Previous Close Market Cap Day's Range 52wk Range Dividend Yield After the close on October 28, Teladoc Health reported Q3 2026 results showing revenue fell 3% to $605.1 million, exceeding the $588.4 million analyst consensus. On the bottom line, Teladoc Health posted a net loss of $0.15 per share, smaller than the Wall Street analysts' consensus loss of $0.21. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) at Teladoc Health rose 14% to $79.4 million, ahead of the Wall Street analysts' consensus of $68.08 million. Within the business, Teladoc's Integrated Care segment revenue rose 2% to $398.5 million with an adjusted EBITDA margin of 18.8%, up from 17%, while BetterHelp revenue fell 13% to $206.6 million as fewer users paid out of pocket. BetterHelp's insurance-covered services revenue reached $32.1 million, up from $3.7 million a year earlier. Teladoc CEO Chuck Divita said, "We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments." Divita added, "In the BetterHelp segment, insurance revenue exceeded our expectations, and we are making encouraging progress expanding provider capacity and scaling access to covered services." For the full year, Teladoc Health expects adjusted EBITDA of $277 million to $303 million. Still, Teladoc Health's Q4 2026 revenue outlook midpoint of $592 million trailed the Wall Street analysts' consensus of $596.6 million. Why Teladoc is pulling away from American Well and Hims & Hers. Teladoc stock is now up 25% year to date (YTD) following the jump. The closest platform comparable is American Well, which sells virtual care to health plans and health systems. Shares of American Well are up 189% YTD. Despite that run, American Well is only inching higher as Teladoc rises. Free Report, Just Released Why Didn't HIMS Make The Top 10 List? 24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now. And HIMS didn't make the cut! The report is free, and you can see why we think each stock is a top investment today. American Well operates as a business-to-business software vendor, selling Amwell Converge, SilverCloud and Carepoint subscriptions to payers, providers and the Defense Health Agency. That setup leaves American Well without a direct-to-consumer therapy arm, so it carries no cash-pay decline of the kind weighing on BetterHelp. Hims & Hers runs a consumer cash-pay telehealth platform built on its own branded products, and the stock is down 8% this year. The company is moving its U.S. weight-loss offering toward branded glucagon-like peptide-1 (GLP-1) medications. Such a cash-pay model runs opposite to Teladoc's effort to put BetterHelp therapy under insurance coverage. Physician tools maker Doximity (NYSE:DOCS | DOCS Price Prediction) is at $34.11, down 0.41%. Year to date, Doximity is down 23%, trailing Teladoc Health. Across the sector, the Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is at $183.48, up 2%, a far smaller gain than Teladoc Health's. Can Teladoc turn insurance gains into revenue growth? Teladoc still faces a key question: whether insurance-covered BetterHelp revenue grows fast enough to offset the cash-pay decline. Teladoc's management is aiming for an annualized BetterHelp insurance revenue run rate of at least $200 million exiting 2027, while Divita noted the company expects "ongoing challenges in cash pay going forward." Teladoc's wider Integrated Care margin and a fourth consecutive quarterly earnings beat give bulls reason for hope. The bears can cite a shrinking BetterHelp paying-user base and $997.6 million of convertible senior notes now classified as current. A return to companywide revenue growth would require the insurance ramp to outpace that cash-pay erosion. Investors may want to track how the BetterHelp insurance transition develops over the coming quarters. Got $1,000? Before you buy HIMS, read this. If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And HIMS wasn't one of them. They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list ->> David Moadel David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.With a master's degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

Teladoc targets at least $200 million BetterHelp insurance run rate by 2027 exit. Teladoc projects $99 million to $105 million in BetterHelp insurance revenue for 2026 and reported third-quarter revenue of $605 million. Published Oct 29, 2026, 5:44 AM EDT Teladoc Health is targeting an annualized run rate of at least $200 million for BetterHelp's insurance business as 2027 ends. The company also plans to repurchase convertible notes. Discover more Crypto market news Blockchain news updates Crypto payment solutions The target describes the yearly pace of insurance revenue at the end of 2027, rather than a forecast for BetterHelp's total revenue during that calendar year. For 2026, Teladoc projects $99 million to $105 million in insurance revenue for BetterHelp. The company expects BetterHelp's cash-pay revenue to remain under pressure and plans to reduce advertising in the fourth quarter. These expectations come as Teladoc seeks to grow insurance-covered care while managing weakness in its cash-pay business. Teladoc's third-quarter revenue was $605 million, down 3.4% from a year earlier. Adjusted EBITDA reached $79 million, up 13.5% year over year. For 2026, Teladoc forecasts total revenue of $2.39 billion to $2.44 billion and adjusted EBITDA of $277 million to $303 million. Its $605 million third-quarter result landed within the company's earlier revenue outlook of $569 million to $609 million, near the upper end of that range. That outlook also projected a 12.3% to 24.2% year-over-year decline in BetterHelp revenue, as detailed in its earlier third-quarter outlook. BetterHelp generated $212.6 million in second-quarter revenue, down 12% from a year earlier. Integrated Care revenue rose 1% to $394.3 million, while Teladoc's total revenue was $606.9 million, down 4% from the prior year. BetterHelp's adjusted EBITDA margin was 0.2% in that quarter. Teladoc's previous third-quarter outlook put the margin at 0.5% to 2.5% for BetterHelp and 15.7% to 17.2% for Integrated Care. John Kim. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to [email protected].

Teladoc Health reported third-quarter revenue of $605 million, down 3.4% from a year earlier, as growth in Integrated Care and BetterHelp insurance offset weaker BetterHelp cash-pay sales. Adjusted EBITDA rose 13.5% to $79 million, and the net loss narrowed to $0.15 per share from $0.28. Integrated Care revenue rose 2.3% to $398 million. BetterHelp revenue fell 12.8% to $207 million, though its insurance revenue reached $32 million, up $10 million from the previous quarter. Teladoc raised its 2026 revenue outlook to $2.39 billion to $2.44 billion. It also plans to address $1 billion in convertible notes due June 2027, possibly by repurchasing a large share before year-end.